- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04064424
Cancer Prevention & Online Technologies
January 10, 2024 updated by: Stanford University
The overall goal of this research is to develop interventions that leverage online technology (e.g.
ads, social media) to reduce individuals' skin-cancer-related risk behaviors and ultimately to reduce skin cancer incidence.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This research includes three phases:
- To better understand the motivators and inhibitors of skin cancer risk behaviors in various populations including use of indoor tanning and outdoor sun exposure;
- To develop content messages and images related to skin cancer risk that are resonant with various populations;
- To test the relative effectiveness of these messages in reducing likelihood of or actual skin cancer risk behaviors in various populations.
Study Type
Interventional
Enrollment (Estimated)
720000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lily Morrison
- Phone Number: 650-723-6109
- Email: Lily.morrison@stanford.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Facebook user between the age of 18 and 65
- Self-identifies as male
- Profile indicates interest in at least one of the following: LGBT community, LGBT culture, LGBT social movements, Rainbow flag, Gay pride, GAY-friendly, homosexuality
Exclusion Criteria:
- Failure to meet inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prevention Advertisement
Participants will be exposed to prevention videos and images through Facebook Advertising
|
Skin Cancer Prevention videos
Skin Cancer Prevention images
|
Active Comparator: No Advertisement
No prevention videos and images will be shown through Facebook Advertising
|
No skin cancer prevention videos or images were advertised.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure intent to tan
Time Frame: 4 weeks
|
Intent to tan will be measured by our follow-up survey question.
Rates of each response will be compared between experimental groups.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure awareness of indoor tanning risk
Time Frame: 4 weeks
|
Awareness of indoor tanning risk will be measured by our follow-up survey question.
Rates of each response will be compared between experimental groups.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eleni Linos, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2024
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
November 1, 2024
Study Registration Dates
First Submitted
August 19, 2019
First Submitted That Met QC Criteria
August 19, 2019
First Posted (Actual)
August 21, 2019
Study Record Updates
Last Update Posted (Actual)
January 11, 2024
Last Update Submitted That Met QC Criteria
January 10, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-50303 (Other Identifier: Stanford-IRB)
- SKIN0049 (Other Identifier: OnCore)
- 1DP2CA225433-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Cancer
-
University of HawaiiVA Palo Alto Health Care SystemCompletedCancer, Other Than Non-melanoma Skin CancerUnited States
-
EnlundCompletedBreast Cancer | Skin Cancer | Colo-rectal CancerSweden
-
McMaster UniversityRecruitingSkin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient SatisfactionCanada
-
SciBase ABRecruitingKeratinocyte Skin CancerGermany
-
Rutgers, The State University of New JerseyCompleted
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedSkin Cancer PreventionUnited States
-
Xoft, Inc.Eminence Clinical Research, Inc.UnknownNonmelanoma Skin CancerUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedSkin Cancer PreventionUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingSkin Cancer, Non-MelanomaFrance
-
Technische Universität DresdenCompletedNon-melanoma Skin CancerGermany
Clinical Trials on Prevention video advertisement
-
Medical College of WisconsinCompleted
-
University of Illinois at ChicagoNational Cancer Institute (NCI); University of Iowa; Truth InitiativeCompleted
-
Memorial University of NewfoundlandRecruiting
-
Centers for Disease Control and PreventionCompletedHIV Infections | Sexually Transmitted DiseasesUnited States
-
Fraser HealthCompletedSuicidal Ideation | Psychiatric Illness | Suicide AttemptsCanada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedWaterpipe Tobacco SmokingUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)Completed
-
Virginia Commonwealth UniversityVirginia Tobacco Settlement Foundation (VTSF)Completed
-
Northwell HealthNational Institute of Mental Health (NIMH)CompletedSchizophrenia | First Episode PsychosisUnited States
-
Christophe BerkhoutUniversity Hospital, LilleCompletedInfluenza, Human | Health Behavior | Vaccination